AAP
PAHC icon

Arax Advisory Partners’s Phibro Animal Health PAHC Stock Holding History

Arax Advisory Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Buy
554
+498
+889% +$21K ﹤0.01% 4054
2026
Q1 		$3.1K Sell
56
-175
-76% -$8.33K ﹤0.01% 2971
2025
Q4 		$8.63K Sell
231
-283
-55% -$11.5K ﹤0.01% 2546
2025
Q3 		$20.8K Buy
514
+449
+691% +$14.8K ﹤0.01% 2249
2025
Q2 		$1.66K Buy
+65
New +$1.42K ﹤0.01% 2629
2025
Q1 		– Sell
-389
Closed -$8.17K – 2947
2024
Q4 		$8.17K Hold
389
– – ﹤0.01% 1560
2024
Q3 		$8.76K Hold
389
– – ﹤0.01% 1476
2024
Q2 		$6.52K Buy
+389
New +$6.25K ﹤0.01% 1472

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Arax Advisory Partners's PAHC Position: Q2 2026 in Review

Arax Advisory Partners increased its Phibro Animal Health (PAHC) stake by 889% in Q2 2026, buying an estimated $21K and bringing the position to 554 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4054.

Arax Advisory Partners first reported a position in PAHC in Q2 2024 and has held it in 8 quarters since. The position peaked at $20.8K in Q3 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Arax Advisory Partners held 554 shares of Phibro Animal Health worth $17.4K as of Q2 2026.
  • Arax Advisory Partners bought 498 Phibro Animal Health shares in Q2 2026, an estimated $21K.
  • Phibro Animal Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4054 holding.
  • Arax Advisory Partners first reported a position in Phibro Animal Health in Q2 2024 and has held it in 8 quarters since.
  • Arax Advisory Partners's Phibro Animal Health position peaked at $20.8K in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.